According to media reports, Paul Stoffels, Galapagos' previous CEO, has assembled a group of investors to bid for the company's cell therapy business. After joining Galapagos in 2022, Paul Stoffels pivoted the company towards cell therapies and focussed the company's efforts on de-centralised CAR-T manufacturing as a way to broaden access to such treatments. Following his resignation earlier this year, he now has placed a non-binding offer for the cell therapy business which is under strategic r...
DEME secures sizable contract for Nordseecluster B wind farm in Germany DEME has secured a sizable contract to carry out the transport and installation works for the inter-array cables for the Nordseecluster B offshore wind farm in Germany. The Nordseecluster is a joint offshore wind project of RWE (51%) and Norges Bank Investment Management (49%). Attachment
DEME wint omvangrijk contract voor het Nordseecluster B windpark in Duitsland DEME heeft een omvangrijk contract binnengehaald voor het transport en de installatie van de inter-array kabels voor het offshore windpark Nordseecluster B in Duitsland. De Nordseecluster is een gezamenlijk offshore windproject van RWE (51%) en Norges Bank Investment Management (49%). Bijlage
Belgian telcos: Digi launches new mobile offer at €7 per month with 30GB D'Ieteren: Belgium Sept car registration, Febiac cuts 2025 outlook to 405-410k new cars Dutch insurance: Achmea Sixth Steet JV done, new entrant for buyouts for ASR and NN Heijmans: I'm a steamroller baby Prosus: Just Eat Takeaway offer unconditional WDP: €22m investment in Romania
Galapagos announced that it has received a limited number of non-binding offers from consortia, predominantly comprised of financial investors, to acquire the cell therapy business. The deadline for potential bidders to put forward binding, fully-financed, offers is in the coming weeks. The company will make an announcement on the outcome of the review of strategic alternatives for the cell therapy business no later than its 3Q25 update on 5 November 2025. € 37 TP and ACCUMULATE reiterated.
In this October update of our Dynamic Top Pick List we are removing VGP while adding Shurgard and Wolters Kluwer. Since its recent inclusion in our Dynamic Top Pick List in July-25, VGPs share rose by 10.6%. While we still believe there is significant upside to the share price, we don't see short term catalysts. In fact, the macro picture remains cloudy with the jury still out on the impact of tariffs and the erratic US policy shifts. Also, we are a bit concerned that competition in Western Eur...
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of Directors (the “Board”) had decided to explore all strategic alternatives for its cell therapy business (the “Cell Therapy Business”), including a potential divestiture of the Cell Therapy Business, with the goal of preserving shareholder value. As part of its review of strategic alternatives, over ...
Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten Mechelen, België; 1 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) en haar Raad van Bestuur hebben vandaag de volgende verklaring uitgegeven: Op 13 mei 2025 kondigde Galapagos aan dat haar Raad van Bestuur (de “Raad”) had besloten om alle strategische alternatieven voor haar celtherapieactiviteiten (de “Celtherapieactiviteiten”) te verkennen, met inbegrip van een mogelijke verkoop van de Celtherapieactiviteiten, met als doel het waarborgen van aandeelhouderswaarde. Als onderdeel...
Belgian telecoms: Telenet increases its fixed internet speed at unchanged price Colruyt: FY25/26F profitability guidance maintained despite market share loss Corbion: Keep Calm and Carry On Fagron: Acquires UCP, adding to its 503A health and wellness offering in California GBL: Planning ahead to deliver on its promise OCI: Limited details on Orascom merger, sales process for Nitrogen Europe ongoing TKH Group: Mixed emotions Wolters Kluwer: Launches UpToDate Expert AI
DEME awarded substantial contract for Formosa 4 offshore wind farm in Taiwan DEME, through its Taiwanese joint venture CDWE, has secured a substantial contract for the Formosa 4 offshore wind farm in Taiwan, covering the transport and installation of 35 foundations and the offshore substation, as well as the scour protection works. Attachment
DEME haalt substantieel contract binnen voor Formosa 4 offshore windpark in Taiwan DEME heeft, via zijn Taiwanese joint venture CDWE, een substantieel contract binnengehaald voor het offshore windpark Formosa 4 in Taiwan. Het contract omvat het transport en de installatie van 35 funderingen en het offshore substation, evenals de werkzaamheden voor erosiebescherming. Bijlage
DEME orders Offshore Construction Vessel to strengthen subsea cable installation capacity DEME is expanding its fleet with a new Offshore Construction Vessel (OCV), strengthening its subsea cable installation capacity to meet the evolving global offshore wind market. Designed for versatility, the vessel will be capable of executing trenching, burial, and cable-laying operations, complementing DEME’s existing cable installation vessels, Living Stone and Viking Neptun. Attachment
DEME bestelt offshore constructieschip om kabelinstallatiecapaciteit te versterken DEME breidt zijn vloot uit met een nieuw offshore constructieschip (Offshore Construction Vessel - OCV) om de capaciteit voor de installatie van onderzeese kabels te vergroten en in te spelen op de dynamische wereldwijde offshore windmarkt. Het multifunctionele schip zal worden ingezet voor trenching, ingraven van kabels en kabellegwerkzaamheden en vormt een aanvulling op DEME’s bestaande kabelinstallatieschepen Living Stone en Viking Neptun. Bijlage
B&S: Sarabel launches recommended all cash offer; Belgian Telecoms: Digi confirms possible minority stake disposal in Spain; market test for Flanders cooperation agreement due any time; Exor: Great companies outperforming the benchmark; PostNL: Feedback on Capital Markets Day event 2025 - new strategy and ambitions 2028; UCB: Encouraging P2a data for Galvokimig in Atopic Dermatitis; Wolters Kluwer: Accelerating share buyback programme and good start to 2H25
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.